These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 18584926

  • 1. Efficient generation of survivin-specific cytotoxic T lymphocytes from healthy persons in vitro: quantitative and qualitative effects of CD4+ T cells.
    Kim EK, Cho HI, Yoon SH, Park MJ, Sohn HJ, Kim HJ, Oh ST, Kim TG.
    Vaccine; 2008 Jul 29; 26(32):3987-97. PubMed ID: 18584926
    [Abstract] [Full Text] [Related]

  • 2. Anti-tumor immunity against nasopharyngeal carcinoma by means of LMP2A-specific cytotoxic T lymphocytes induced by dendritic cells.
    Xu JJ, Yao K, Yu CJ, Chen X, Lu MP, Sun H, Li BZ, Ding CN, Zhou F.
    Auris Nasus Larynx; 2006 Dec 29; 33(4):441-6. PubMed ID: 16934422
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cells with transduced survivin gene induce specific cytotoxic T lymphocytes in human urologic cancer cell lines.
    Kikkawa K, Fujii R, Kuramoto T, Mori T, Inagaki T, Kohjimoto Y, Iwahashi M, Yamaue H, Hara I.
    Urology; 2009 Jul 29; 74(1):222-8. PubMed ID: 19285711
    [Abstract] [Full Text] [Related]

  • 4. alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in Vitro.
    Cao DY, Yang JY, Dou KF, Ma LY, Teng ZH.
    Hum Immunol; 2007 May 29; 68(5):334-41. PubMed ID: 17462500
    [Abstract] [Full Text] [Related]

  • 5. Green fluorescent protein expression in dendritic cells enhances their immunogenicity and elicits specific cytotoxic T-cell responses in humans.
    Re F, Srinivasan R, Igarashi T, Marincola F, Childs R.
    Exp Hematol; 2004 Feb 29; 32(2):210-7. PubMed ID: 15102483
    [Abstract] [Full Text] [Related]

  • 6. Enhanced induction of anti-tumor immunity in human and mouse by dendritic cells pulsed with recombinant TAT fused human survivin protein.
    Cho HI, Kim EK, Park SY, Lee SK, Hong YK, Kim TG.
    Cancer Lett; 2007 Dec 18; 258(2):189-98. PubMed ID: 17931768
    [Abstract] [Full Text] [Related]

  • 7. Dendritic cells adenovirally-transduced with full-length mesothelin cDNA elicit mesothelin-specific cytotoxicity against pancreatic cancer cell lines in vitro.
    Miyazawa M, Iwahashi M, Ojima T, Katsuda M, Nakamura M, Nakamori M, Ueda K, Naka T, Hayata K, Iida T, Yamaue H.
    Cancer Lett; 2011 Jun 01; 305(1):32-9. PubMed ID: 21397388
    [Abstract] [Full Text] [Related]

  • 8. Generation of survivin-specific CD8+ T effector cells by dendritic cells pulsed with protein or selected peptides.
    Schmitz M, Diestelkoetter P, Weigle B, Schmachtenberg F, Stevanovic S, Ockert D, Rammensee HG, Rieber EP.
    Cancer Res; 2000 Sep 01; 60(17):4845-9. PubMed ID: 10987296
    [Abstract] [Full Text] [Related]

  • 9. Transfection of dendritic cells with in vitro-transcribed CMV RNA induces polyclonal CD8+- and CD4+-mediated CMV-specific T cell responses.
    Heine A, Grünebach F, Holderried T, Appel S, Weck MM, Dörfel D, Sinzger C, Brossart P.
    Mol Ther; 2006 Feb 01; 13(2):280-8. PubMed ID: 16219490
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Tat mammaglobin fusion protein transduced dendritic cells stimulate mammaglobin-specific CD4 and CD8 T cells.
    Viehl CT, Tanaka Y, Chen T, Frey DM, Tran A, Fleming TP, Eberlein TJ, Goedegebuure PS.
    Breast Cancer Res Treat; 2005 Jun 01; 91(3):271-8. PubMed ID: 15952060
    [Abstract] [Full Text] [Related]

  • 12. Generation of cytotoxic T lymphocytes specific for human cytomegalovirus using dendritic cells in vitro.
    Cho HI, Han H, Kim CC, Kim TG.
    J Immunother; 2001 Jun 01; 24(3):242-9. PubMed ID: 11394502
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Benefits of gene transduction of granulocyte macrophage colony-stimulating factor in cancer vaccine using genetically modified dendritic cells.
    Ojima T, Iwahashi M, Nakamura M, Matsuda K, Nakamori M, Ueda K, Naka T, Katsuda M, Miyazawa M, Yamaue H.
    Int J Oncol; 2007 Oct 01; 31(4):931-9. PubMed ID: 17786327
    [Abstract] [Full Text] [Related]

  • 15. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
    Forsberg O, Carlsson B, Tötterman TH, Essand M.
    Br J Haematol; 2008 Apr 01; 141(2):188-99. PubMed ID: 18307565
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficient induction of specific cytotoxic T lymphocytes to tumor rejection peptide using functional matured 2 day-cultured dendritic cells derived from human monocytes.
    Tanaka F, Yamaguchi H, Haraguchi N, Mashino K, Ohta M, Inoue H, Mori M.
    Int J Oncol; 2006 Nov 01; 29(5):1263-8. PubMed ID: 17016660
    [Abstract] [Full Text] [Related]

  • 18. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
    Eiz-Vesper B, Horn PA, Daubert C, Khattab B, Blasczyk R.
    Transfusion; 2006 Jul 01; 46(7):1210-20. PubMed ID: 16836569
    [Abstract] [Full Text] [Related]

  • 19. Modification of the human allergic immune response by allergen-DNA-transfected dendritic cells in vitro.
    Klostermann B, Bellinghausen I, Böttcher I, Petersen A, Becker WM, Knop J, Saloga J.
    J Allergy Clin Immunol; 2004 Feb 01; 113(2):327-33. PubMed ID: 14767450
    [Abstract] [Full Text] [Related]

  • 20. In vitro anti-tumor immune response induced by dendritic cells transfected with hTERT recombinant adenovirus.
    Chen L, Liang GP, Tang XD, Chen T, Cai YG, Fang DC, Yu ST, Luo YH, Yang SM.
    Biochem Biophys Res Commun; 2006 Dec 29; 351(4):927-34. PubMed ID: 17097054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.